Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung diseases with excess mucus and mucus plugs.
Company Details
Company type
Year founded
2014
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products under development
AER-01, lead mucolytic drug candidate